Boston Scientific is Thursday's IBD Stock Of The Day as the medtech trades just below all-time highs it hit late last month.

Nvidia is IBD Stock Of The Day as the AI chipmaker rises above its 50-day moving average and a downward-sloping trendline.

This China stock hit a buy point of an erratic base. The EV stock has recovered from a sell-off and reached a new high.

AppLovin is the IBD Stock Of The Day as the app marketing platform earns positive reviews for its nascent e-commerce ...

Teva Pharmaceutical (NYSE: TEVA) and Sanofi (NASDAQ: SNY) stocks were rising on Tuesday after the companies announced successful results of a phase 2 study involving the treatment of patients with ...

Sanofi stock rose nearly 7%. Year to date, the stock fell 1.6% against the industry’s 5.3% growth. Zacks Investment Research Image Source: Zacks Investment Research Shares of Teva jumped 26% ...

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report), with a ...

Teva's R&D chief, Eric Hughes, didn't hold back, calling the results beyond expectations, while Sanofi's head of R&D, Houman Ashrafian, described the drug as a frontier in treating IBD.

Piper Sandler analyst Christopher Raymond raised the firm’s price target on AbbVie (ABBV) to $220 from $212 and keeps an Overweight rating on ...